Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement
Yaqui Valenzuela, Medical Science Liaison at Pfizer, shared Jorge Alberto Barragán’s post on LinkedIn:
“Hemophilia is a little-known disease with few treatments that allow patients to lead a good quality of life.
What lies ahead will undoubtedly change the paradigm of this condition—not only improving the patients’ quality of life, but also helping us start to make women visible within it.
We have a great challenge ahead, but I have no doubt that we will also pave the way.
Congratulations!”
Jorge Alberto Barragán, Medical Lead of Specialty Care and Internal Medicine at Pfizer, shared a post on LinkedIn:
“Innovation in hemophilia continues to evolve to address unmet needs that remain in clinical practice.
Beyond the remarkable advances achieved with factor replacement therapies, new therapeutic approaches are expanding treatment possibilities, aiming to reduce treatment burden, improve patient experience, and support more individualized care.
Continued investment in research and access to innovation will be essential to further improve outcomes for people living with hemophilia in Mexico.
Thanks to our speakers: Aída Mashenka Moreno Gonzalez, Akshat Jain, Jimenez Yuste, Ana Laura Alvarez, Garcia Chavez.
Thank you for this great event.”
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 13:42Immune Thrombocytopenia: Moving Beyond Platelet Counts Toward Durable Remission
-
Aug 3, 2026, 13:28Aboo Shama Khan: Pulmonary Embolism – A Medical Emergency Every Nurse Must Recognize
-
Aug 3, 2026, 13:08Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients
-
Aug 3, 2026, 13:03Mohamed El Belghiti Alaoui: The Promise of AAV Gene Therapy in Hemophilia A
-
Aug 3, 2026, 12:44Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
-
Aug 3, 2026, 12:43Shinta C: Takeda Marks a Milestone in Hemophilia Care
-
Aug 3, 2026, 12:37Deepak Kumar Dasmohapatra: Honored for Contributions to Transfusion Medicine and Immunohematology by the Governor of Chhattisgarh
-
Aug 3, 2026, 12:30Furkan Bahar: Thrombotic and Hemorrhagic Risk Profiles in Advanced Melanoma – Targeted vs Immune Combination Therapies
-
Aug 3, 2026, 12:28Tayyaba Iftikhar: When Platelets Talk to Cancer Cells